Babar, Z. and Areesha Babar (2025) “FDA’s New Approval: Kisunla (Donanemab-Azbt) - A Major Breakthrough in Alzheimer’s Care”, Journal of the Pakistan Medical Association, 75(07), pp. 1156–1156. doi: 10.47391/JPMA.21951.